Results 231 to 240 of about 284,066 (339)
Mortality among patients with pleural effusion undergoing thoracentesis
European Respiratory Journal, 2015 Erin M. DeBiasi +6 more
semanticscholar +1 more source
ESC Heart Failure, EarlyView.This systematic review identified 24 clinical trials of medical device and surgical interventions for HFpEF, with 16 demonstrating at least safety and feasibility, but little evidence of long‐term benefit. Phenotype‐based responses suggest that certain interventions may benefit specific HFpEF subgroups, yet most trials suffered from heterogeneous ...
Kurdo Araz +5 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai +4 more
wiley +1 more source
ESC Heart Failure, EarlyView.The aim of our study was to develop a more accurate staging system for hereditary ATTR patients currently receiving specific treatment. A staging system was created using as criteria: GLS ≤ −11%, NT‐proBNP ≤ 2,000 ng/L, and eGFR ≤ 65 mL/min. We managed to accurately stratify patients into three disease stages, significantly different in terms of ...
Gabriela Neculae +7 more
wiley +1 more source
ALBUMINOUS BODIES PRESENT IN PATHOLOGICAL EFFUSIONS. [PDF]
, 1907 OskarC. Gruner
openalex +1 more source
A severe case of buruli ulcer disease with pleural effusions. [PDF]
, 2014 Abass, MK +8 more
core +2 more sources
European Journal of Heart Failure, EarlyView.Right ventricular reverse remodelling after transcatheter tricuspid valve intervention (TTVI). Optimal tricuspid regurgitation (TR) reduction is critical for right ventricular reverse remodelling. CMR, cardiac magnetic resonance; echo, echocardiography; RV EDV, right ventricular end‐diastolic volume. Abstract Aims Right ventricular reverse remodelling (
Ludwig T. Weckbach +16 more
wiley +1 more source